Dr. Adam Melvin, associate professor of chemical and biomolecular engineering at Clemson University, will present “Engineering Preclinical Tumor Models to Study Cancer Drug Resistance and Metastatic Spread.” His research interests focus on biochemical/biomedical engineering including the design of peptide-based biosensors and therapeutics and the development of novel microfluidic platforms to model the breast tumor microenvironment and metastatic cascade as well as performing high-throughput single cell analysis.